Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Henry Khederian

EXPLAINED: What s going on with moderna shares - The Real Truth

Shares of vaccine companies, including Moderna Inc (NASDAQ:MRNA), are trading higher amid COVID-19 concerns due to rising cases in China.

Rising COVID-19 cases in China's capital Beijing and Shanghai, where enforcement of a strict "zero-COVID" policy is ongoing, have drawn global attention. 

The world's second-largest economy has been struggling to completely stamp out the pandemic as traders and investors weigh increasing infections in the region.

See Also: Why Axsome Therapeutics Stock Is Falling Today

Moderna’s mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020.

According to data from Benzinga Pro, Moderna has a 52-week high of $497.49 and a 52-week low of $122.01.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.